Therapeutic Modalities in Diabetic Nephropathy: Standard and Emerging Approaches
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic Modalities in Diabetic Nephropathy: Standard and Emerging Approaches
Authors
Keywords
-
Journal
JOURNAL OF GENERAL INTERNAL MEDICINE
Volume 27, Issue 4, Pages 458-468
Publisher
Springer Nature
Online
2011-10-18
DOI
10.1007/s11606-011-1912-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of Additive Therapy With Spironolactone on Proteinuria in Diabetic Patients Already on ACE Inhibitor or ARB Therapy
- (2016) Mohammad G. Saklayen et al. JOURNAL OF INVESTIGATIVE MEDICINE
- The Effect of Comorbid Illness and Functional Status on the Expected Benefits of Intensive Glucose Control in Older Patients with Type 2 Diabetes: A Decision Analysis
- (2013) Elbert S. Huang et al. ANNALS OF INTERNAL MEDICINE
- Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the Renin–Angiotensin System on Proteinuria in Renal Disease
- (2013) Regina Kunz et al. ANNALS OF INTERNAL MEDICINE
- Effect of Bardoxolone Methyl on Kidney Function in Patients with T2D and Stage 3b–4 CKD
- (2011) Pablo E. Pergola et al. AMERICAN JOURNAL OF NEPHROLOGY
- Diabetes, Hypertension, and Outcome Studies: Overview 2010
- (2011) P. M. Nilsson et al. DIABETES CARE
- Risk of Acute Myocardial Infarction, Stroke, Heart Failure, and Death in Elderly Medicare Patients Treated With Rosiglitazone or Pioglitazone
- (2010) David J. Graham et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Tight Blood Pressure Control and Cardiovascular Outcomes Among Hypertensive Patients With Diabetes and Coronary Artery Disease
- (2010) Rhonda M. Cooper-DeHoff et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Systolic blood pressure and risk of cardiovascular diseases in type 2 diabetes: an observational study from the Swedish national diabetes register
- (2010) Jan Cederholm et al. JOURNAL OF HYPERTENSION
- Avosentan for Overt Diabetic Nephropathy
- (2010) J. F.E. Mann et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase
- (2010) Vishal S. Vaidya et al. KIDNEY INTERNATIONAL
- Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial
- (2010) Dick de Zeeuw et al. LANCET
- Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial
- (2010) George L Bakris et al. LANCET
- Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial
- (2010) Faramarz Ismail-Beigi et al. LANCET
- Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Progression of Chronic Kidney Disease
- (2009) D. Bolignano et al. Clinical Journal of the American Society of Nephrology
- Supramaximal Dose of Candesartan in Proteinuric Renal Disease
- (2009) E. Burgess et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Lowering Blood Pressure Reduces Renal Events in Type 2 Diabetes
- (2009) B. E. de Galan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy
- (2009) U. F. Mehdi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Endothelin-1 levels and albuminuria in patients with type 2 diabetes mellitus
- (2008) Claudete M. Zanatta et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study
- (2008) G.L. Bakris et al. KIDNEY INTERNATIONAL
- Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial
- (2008) Johannes FE Mann et al. LANCET
- Effect of eplerenone, enalapril and their combination treatment on diabetic nephropathy in type II diabetic rats
- (2008) Y. S. Kang et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
- (2008) Hans-Henrik Parving et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aliskiren and Dual Therapy in Type 2 Diabetes Mellitus
- (2008) Julie R. Ingelfinger NEW ENGLAND JOURNAL OF MEDICINE
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes
- (2008) Peter Gæde et al. NEW ENGLAND JOURNAL OF MEDICINE
- Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients
- (2008) Kenneth Jamerson et al. NEW ENGLAND JOURNAL OF MEDICINE
- 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
- (2008) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
- (2008) William Duckworth et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Effects of Spironolactone on Nephron Function in Patients with Diabetic Nephropathy
- (2008) Ayten Ustundag et al. RENAL FAILURE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started